Key takeaways
Truvada (emtricitabine/tenofovir disoproxil fumarate) and Edurant (rilpivirine) are both medications used to treat HIV, but they have some key differences. Truvada is a combination of two nucleoside reverse transcriptase inhibitors (NRTIs) and is also used for HIV prevention (PrEP). It is taken once daily and is available as a lower-cost generic. Common side effects include nausea, diarrhea, and dizziness. Edurant, on the other hand, is a non-nucleoside reverse transcriptase inhibitor (NNRTI) and is only used for treating HIV, not for prevention. It must be taken with a meal and is only available as a brand-name medication. Additionally, Edurant is sometimes used short-term before starting Cabenuva injections. Side effects of both medications include depression, headache, and trouble sleeping. Both medications require regular blood tests to monitor for side effects and effectiveness, but Truvada has a higher risk of causing bone and kidney problems compared to Edurant.
